Mr. Hall is a serial entrepreneur and impact investor. He brings extensive experience in the technology, biotechnology and cleantech sectors, with particular expertise in deal-making, strategic planning, and market development and commercialization. Known as a visionary who sees a clear path to success, Mr. Hall has proven the ability to drive research-based technology into profitable commercialization.
As a serial entrepreneur, Mr. Hall was co-founder and president of Aspreva Pharmaceuticals, taking the company from start-up to profitability and over a billion-dollar market cap in seven years. He is also the co-founder and board chair of Creatus Biosciences and Melio Peptide systems, co-founder and board director of Arius Technology, and former board director for Zymeworks and former founder and Exec Chair of Vitaeris Bio.
Mr. Hall is currently co-director of Machall Investments, a family office focused on the Healthcare, Technology and Cleantech sectors with a particular interest in sustainability. He is also a Creative Destruction Lab (CDL) mentor focusing on advising startup ag-tech companies.